Business
Notice of AGM
Notice of AGM.
About this update from Fortis Frontier Plc
[{"type":"text","content":"\n \nRNS Number : 6826Z Concepta PLC 21 May 2019 \n\n \n \n \nNotice of Annual General Meeting \n \nConcepta Plc (AIM: CPT), the innovative UK personalised healthcare company and developer of the proprietary self-test platform (\"myLotus®\") and suite of emerging test products targeting the mobile health market with a primary focus on women's fertility and hormone health, confirms the Notice of Annual General Meeting (\"AGM\") and associated form of proxy will be sent to shareholders today, Tuesday 21 May.\n \nThe Company's AGM will be held at The Exchange, Colworth Science Park, Sharnbrook, Bedfordshire, MK444 1LZ at 9.30am on Thursday 13 June 2019.\n \nThe Annual Report and Accounts, Notice of AGM and associated form of proxy are available on the Company's website at www.conceptaplc.com.\n \nEnquiries\nCompany: www.conceptaplc.com, Product: www.mylotus.com\nMatthew Walls, Chairman\nTel: +44 (0) 1234 866601\n \nSPARK Advisory Partners Limited (Nomad)\nNeil Baldwin\nTel: +44 (0)20 368 3550\n \nNovum Securities \nColin Rowbury\n+44 (0) 20 7399 9400\n \nAbout Concepta Plc: \nConcepta Plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus®, targeted at the personalised mobile health market with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant and to provide insight to unexplained infertility.\n \nmyLotus® is currently the only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception rates and early diagnosis of fertility issues. The proposition of myLotus® is to empower women to better understand their hormone levels and menstrual cycle and help women conceive naturally by identifying their window of fertility and optimal time for conception.\n \nThe Company has received CE-mark certification for myLotus® and has launched its first product in the UK. The Company is preparing plans to roll-out across the core EU countries in 2019. \n \nmyLotus® is expected to be beneficial to users who have been unable to conceive after 6 months of trying. Thi...